Efficacy and safety of 2 low-dose regimens of conjugated estrogen cream administered vaginally in postmenopausal women with atrophic vaginitis

Trial Profile

Efficacy and safety of 2 low-dose regimens of conjugated estrogen cream administered vaginally in postmenopausal women with atrophic vaginitis

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2009

At a glance

  • Drugs Conjugated estrogens (Primary)
  • Indications Atrophic vaginitis; Menopausal syndrome; Vaginitis
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Most Recent Events

    • 16 Jul 2009 Results reported in Menopause, July/August 2009 issue, according to Wyeth media release.
    • 27 Sep 2008 Results reported at 2008 NAMS.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top